Cargando…

Novel approaches to combat chemoresistance against glioblastomas

The poor prognosis of glioblastoma multiforme (GBM) patients is in part due to resistance to current standard-of-care treatments including chemotherapy [predominantly temozolomide (TMZ; Temodar)], radiation therapy and an anti-angiogenic therapy [an antibody against the vascular endothelial growth f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Towner, Rheal A., Zalles, Michelle, Saunders, Debra, Smith, Nataliya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992560/ https://www.ncbi.nlm.nih.gov/pubmed/35582224 http://dx.doi.org/10.20517/cdr.2020.38

Ejemplares similares

XRN2 Is Required for Cell Motility and Invasion in Glioblastomas
por: Dang, Tuyen T., et al.
Publicado: (2022)

A tale of two multi‐focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone‐based OKN‐007
por: Zalles, Michelle, et al.
Publicado: (2021)

Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model()()
por: Zalles, Michelle, et al.
Publicado: (2020)

OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma
por: Thomas, Lincy, et al.
Publicado: (2020)

MRI as a Tool to Assess Interstitial Cystitis Associated Bladder and Brain Pathologies
por: Towner, Rheal A., et al.
Publicado: (2021)

ELTD1 as a multi-focal target for malignant gliomas: preclinical studies
por: Zalles, Michelle, et al.
Publicado: (2021)

In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis
por: Smith, Nataliya, et al.
Publicado: (2020)

OKN-007 Alters Protein Expression Profiles in High-Grade Gliomas: Mass Spectral Analysis of Blood Sera
por: Towner, Rheal A., et al.
Publicado: (2022)

Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts
por: Coutinho de Souza, Patricia, et al.
Publicado: (2015)

Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model
por: Zalles, Michelle, et al.
Publicado: (2019)

A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model
por: Towner, Rheal A., et al.
Publicado: (2015)

Using MRI to measure in vivo free radical production and perfusion dynamics in a mouse model of elevated oxidative stress and neurogenic atrophy
por: Ahn, Bumsoo, et al.
Publicado: (2019)

AG488 as a therapy against gliomas
por: Ziegler, Jadith, et al.
Publicado: (2017)

Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
por: Sridharan, Sangita, et al.
Publicado: (2019)

Targeting Nrf2 Signaling to Combat Chemoresistance
por: No, Jae Hong, et al.
Publicado: (2014)

Physical Forces in Glioblastoma Migration: A Systematic Review
por: Grossen, Audrey, et al.
Publicado: (2022)

OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth()()
por: Towner, Rheal A., et al.
Publicado: (2018)

Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas
por: He, Ting, et al.
Publicado: (2011)

SuperGAG biopolymers for treatment of excessive bladder permeability
por: Towner, Rheal A., et al.
Publicado: (2021)

Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
por: Dissanayake, Ranga, et al.
Publicado: (2023)

Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
por: Anderson, George
Publicado: (2020)

In Vivo Imaging of Immuno-Spin Trapped Radicals With Molecular Magnetic Resonance Imaging in a Diabetic Mouse Model
por: Towner, Rheal A., et al.
Publicado: (2012)

Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
por: Da Ros, Martina, et al.
Publicado: (2018)

Novel and emerging approaches to combat adolescent obesity
por: Sharma, Manoj, et al.
Publicado: (2010)

New Approach to Combat Glioblastoma Shows Promise in Preclinical Studies
Publicado: (2006)

Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury
por: Du, Xiaoping, et al.
Publicado: (2016)

Gestational hypoxia disrupts the neonatal leptin surge and programs hyperphagia and obesity in male offspring in the Sprague-Dawley rat
por: Vargas, Vladimir E., et al.
Publicado: (2017)

Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
por: Beier, Dagmar, et al.
Publicado: (2011)

Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
por: Kang, Hyunkoo, et al.
Publicado: (2022)

Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance
por: Nguyen, Ha S., et al.
Publicado: (2018)

CRISPR systems: Novel approaches for detection and combating COVID-19
por: Safari, Fatemeh, et al.
Publicado: (2021)

Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects
por: Rajagopalan, Viswanathan, et al.
Publicado: (2016)

The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
por: Lei, Yuhe, et al.
Publicado: (2022)

DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma
por: Jia, Xuebing, et al.
Publicado: (2022)

Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells
por: Peña Agudelo, Jorge A., et al.
Publicado: (2023)

Feasibility Evaluation of Detecting Hydroxymethylphosphine Oxide In Vivo by (31)P-MRS
por: Doblas, Sabrina, et al.
Publicado: (2010)

Combat as an Interpersonal Synergy: An Ecological Dynamics Approach to Combat Sports
por: Krabben, Kai, et al.
Publicado: (2019)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics
por: Mubeen, Bismillah, et al.
Publicado: (2021)

Mitochondrial DNA-targeted therapy: A novel approach to combat cancer
por: Lin, Yumeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bi474j3n6cieu03igorqpv5rqv